Therefore, the decreased GGT activity occurring during hypertension may be balanced by an oxidative stress-related increase in PDI expression and/or activity, slightly improving vasorelaxant effects of GSNO in SHR and SHR-S. This evidence concerns the gene P4HB and hypertensive disorder.